Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044649295> ?p ?o ?g. }
- W2044649295 endingPage "825" @default.
- W2044649295 startingPage "813" @default.
- W2044649295 abstract "The antioxidant and cardioprotective effects of the beta-adrenoceptor antagonist, carvedilol, and its hydroxylated analog. BM-910228, were compared using the postischemic rat heart model. Hearts were infused with either agent (0.01, 0.10, or 10 nM final, or drug-free infusate) for 10 min prior to 30 min global ischemia, and also during the initial 15 min of reperfusion. Recovery of postischemic hemodynamic parameters (left ventricular systolic and developed pressures, mean diastolic pressure, cardiac output, coronary flow rate, and cardiac pressure-volume work), and the extent of postischemic tissue lactate dehydrogenase (LDH) loss, lipid hydroperoxide (LOOH) formation, and lipid peroxidation (LPO)-derived free radical production were assessed and compared among the treatment groups. The depressive pharmacological properties (beta- and alpha-blockade) of both agents masked the extent of postischemic hemodynamic recovery, except at the lowest dose (10 pM) of the analog, which provided significant improvements in systolic and developed pressures, and cardiac work. Treatment with both agents provided significant dose-dependent reductions in postischemic LOOH formation and lipid alkoxyl radical production, as determined by electron spin resonance spectroscopy and alpha-phenyl-tert-butylnitrone. (PBN) spin trapping (PBN/alkoxyl adduct hyperfine splitting alpha N = 13.63 G and alpha H = 1.93 G). Although both agents reduced oxidative injury, the hydroxylated analog was clearly the superior antioxidant (equipotent at doses two to three orders of magnitude lower) compared to the parent compound. This was also reflected with respect to three orders of magnitude lower) compared to the parent compound. This was also reflected with respect to drug-mediated improvement in myocardial preservation (reduced LDH release), which paralleled the antioxidant protective effects. Because neither agent displayed significant primary radical scavenging ability at doses (< or = 10 nM), which did provide substantial inhibition of postischemic LOOH and alkoxyl formation, our data suggest that the antioxidant properties of carvedilol and its analog are mediated primarily through a LPO chair-breaking mechanism. Moreover, the significant antioxidant protection afforded by the analog BM-910228 at subnanomolar levels places this agent into an exclusive category reserved for exceptionally potent antioxidants." @default.
- W2044649295 created "2016-06-24" @default.
- W2044649295 creator A5023081124 @default.
- W2044649295 creator A5031105236 @default.
- W2044649295 date "1996-01-01" @default.
- W2044649295 modified "2023-09-24" @default.
- W2044649295 title "A hydroxylated analog of the β-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts" @default.
- W2044649295 cites W1577460994 @default.
- W2044649295 cites W1964586793 @default.
- W2044649295 cites W1968134494 @default.
- W2044649295 cites W1973494669 @default.
- W2044649295 cites W1975866612 @default.
- W2044649295 cites W1977406783 @default.
- W2044649295 cites W1979871079 @default.
- W2044649295 cites W1998996067 @default.
- W2044649295 cites W2000949681 @default.
- W2044649295 cites W2005736060 @default.
- W2044649295 cites W2006382089 @default.
- W2044649295 cites W2007108784 @default.
- W2044649295 cites W2011375069 @default.
- W2044649295 cites W2012384153 @default.
- W2044649295 cites W2014254974 @default.
- W2044649295 cites W2025237767 @default.
- W2044649295 cites W2042727548 @default.
- W2044649295 cites W2042772970 @default.
- W2044649295 cites W2045517901 @default.
- W2044649295 cites W2046348800 @default.
- W2044649295 cites W2050561156 @default.
- W2044649295 cites W2050817800 @default.
- W2044649295 cites W2054526264 @default.
- W2044649295 cites W2061242359 @default.
- W2044649295 cites W2065993163 @default.
- W2044649295 cites W2071364046 @default.
- W2044649295 cites W2077088558 @default.
- W2044649295 cites W2079508770 @default.
- W2044649295 cites W2084789091 @default.
- W2044649295 cites W2091962917 @default.
- W2044649295 cites W2095561521 @default.
- W2044649295 cites W2099130096 @default.
- W2044649295 cites W2121641608 @default.
- W2044649295 cites W2131741252 @default.
- W2044649295 cites W2143254074 @default.
- W2044649295 cites W2169526645 @default.
- W2044649295 cites W2171980278 @default.
- W2044649295 cites W2241986638 @default.
- W2044649295 doi "https://doi.org/10.1016/0891-5849(96)00184-0" @default.
- W2044649295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8902527" @default.
- W2044649295 hasPublicationYear "1996" @default.
- W2044649295 type Work @default.
- W2044649295 sameAs 2044649295 @default.
- W2044649295 citedByCount "49" @default.
- W2044649295 countsByYear W20446492952012 @default.
- W2044649295 countsByYear W20446492952013 @default.
- W2044649295 countsByYear W20446492952014 @default.
- W2044649295 countsByYear W20446492952016 @default.
- W2044649295 countsByYear W20446492952017 @default.
- W2044649295 crossrefType "journal-article" @default.
- W2044649295 hasAuthorship W2044649295A5023081124 @default.
- W2044649295 hasAuthorship W2044649295A5031105236 @default.
- W2044649295 hasConcept C126322002 @default.
- W2044649295 hasConcept C170493617 @default.
- W2044649295 hasConcept C178853913 @default.
- W2044649295 hasConcept C181199279 @default.
- W2044649295 hasConcept C185592680 @default.
- W2044649295 hasConcept C26635844 @default.
- W2044649295 hasConcept C2776885963 @default.
- W2044649295 hasConcept C2777318727 @default.
- W2044649295 hasConcept C2778004101 @default.
- W2044649295 hasConcept C2778198053 @default.
- W2044649295 hasConcept C2780591200 @default.
- W2044649295 hasConcept C2780829032 @default.
- W2044649295 hasConcept C55493867 @default.
- W2044649295 hasConcept C71924100 @default.
- W2044649295 hasConcept C98274493 @default.
- W2044649295 hasConceptScore W2044649295C126322002 @default.
- W2044649295 hasConceptScore W2044649295C170493617 @default.
- W2044649295 hasConceptScore W2044649295C178853913 @default.
- W2044649295 hasConceptScore W2044649295C181199279 @default.
- W2044649295 hasConceptScore W2044649295C185592680 @default.
- W2044649295 hasConceptScore W2044649295C26635844 @default.
- W2044649295 hasConceptScore W2044649295C2776885963 @default.
- W2044649295 hasConceptScore W2044649295C2777318727 @default.
- W2044649295 hasConceptScore W2044649295C2778004101 @default.
- W2044649295 hasConceptScore W2044649295C2778198053 @default.
- W2044649295 hasConceptScore W2044649295C2780591200 @default.
- W2044649295 hasConceptScore W2044649295C2780829032 @default.
- W2044649295 hasConceptScore W2044649295C55493867 @default.
- W2044649295 hasConceptScore W2044649295C71924100 @default.
- W2044649295 hasConceptScore W2044649295C98274493 @default.
- W2044649295 hasIssue "6" @default.
- W2044649295 hasLocation W20446492951 @default.
- W2044649295 hasLocation W20446492952 @default.
- W2044649295 hasOpenAccess W2044649295 @default.
- W2044649295 hasPrimaryLocation W20446492951 @default.
- W2044649295 hasRelatedWork W1687510487 @default.
- W2044649295 hasRelatedWork W1966046961 @default.
- W2044649295 hasRelatedWork W2045434592 @default.
- W2044649295 hasRelatedWork W2098127917 @default.